Open (posted) · Grant
DoW Vision, Translational Research Award
Defense Health Agency Contracting Activity - DHACA, Department of Defense
Key facts
Copied from the official Grants.gov record. Last verified October 29, 2026.
- Program name
- DoW Vision, Translational Research Award
- Issuing agency
- Defense Health Agency Contracting Activity - DHACA (Department of Defense)
- Opportunity number
- HT942526VRPTRA
- Funding type
- Grant
- Funding purpose
- Science and Technology and other Research and Development
- Status
- Open (posted)
- Application deadline
- Closes November 12, 2026(14 days left)
- Published award range
- Not published by the agency
- Estimated total program funding
- $1,600,000
- Expected number of awards
- 1
- Cost sharing or match required
- No
- Eligible applicants (official categories)
- Unrestricted (open to any type of entity, subject to any clarification in Additional Information on Eligibility)
- Relevant to
- Businesses and NonprofitsHow we determined this: Grants.gov lists eligibility as Unrestricted.
- Geographic restrictions
- None stated in structured data (federal opportunities are often nationwide). Check the eligibility details and full announcement for any limits.
- Assistance Listing (CFDA)
- 12.420
- Official source
- View on Grants.gov ↗
- Application URL
- www.grants.gov/search-results-detail/362186 ↗Apply through Grants.gov (Workspace) using the application package on the official listing, unless the full announcement names a different submission system.
- Source identifier
- Grants.gov opportunity ID 362186 · Funding opportunity number HT942526VRPTRA
- Posted
- May 5, 2026 · Source last updated May 6, 2026
- Last verified
- October 29, 2026 (against Grants.gov)
- Data completeness
- 83% of key fields published by the sourceNot published: published funding range, eligibility criteria text.
- Record confidence
- highVerified against the official source; key fields present; no open issues.
Description (from the official listing)
Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Translational Research Award (TRA) supports translational research that transforms a promising discovery into new drugs, devices or clinical practice guidelines that are ready for definitive testing in clinical trials during or by the end of the period of performance. The TRA may be used to support preclinical studies, clinical research or a pilot clinical trial, but not a full-scale clinical trial. Research must align with at least one of the FY26 VRP Focus Areas. Distinctive Features: · If developing new drugs or device(s), the research team must include expertise in the regulatory approval process. · The TRA includes a Partnering Principal Investigator (PI) Option (PPIO) for two PIs, an Initiating PI and a Partnering PI. · Scored peer review criteria include Research Idea/Rationale, Research Strategy and Feasibility, Impact, Personnel and Post-Award Transition Plan. · Programmatic review criteria include adherence to the intent of the TRA, contribution to the VRP portfolio, relative impact and relevance to military health. · The VRP may share FY26 TRA applications and reviews with the National Eye Institute (NEI) for independent funding consideration. https://cdmrp.health.mil/pubs/press/2026/vrppreann
Agency contact
eBRAP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org
help@eBRAP.org